| Nicholas Calci, | |
|
2032 New Castle Ave, New Castle, DE 19720-7703 | |
| (302) 654-1700 | |
| Not Available |
| Full Name | Nicholas Calci |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 2032 New Castle Ave, New Castle, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225607211 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Provider Name | Ati Holdings Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1396781050 PECOS PAC ID: 9537112719 Enrollment ID: O20061101000380 |
News Archive
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the completion of a research study, conducted with an independent market research firm, that identified a significant unmet medical need for improved treatments for patients with chronic pain and dysphagia/odynophagia. In clinical practice, dysphagia is most often defined as difficulty in swallowing and odynophagia is defined as pain upon swallowing.
Increased relative risks for coronary heart disease (CHD) have long been associated with smoking, and traditionally they have been dependent on the number of cigarettes smoked a day, smoking intensities, and total exposure over time.
A Cochrane review of evidence to date has cast uncertainty over the magnitude of benefit children with attention deficit/hyperactivity gain by taking methylphenidate.
PrimeraDx, Inc., a privately held molecular diagnostics company, announced today that it has received its fourth patent. The patent, entitled "Methods and systems for dynamic gene expression profiling", with inventor Vladimir Slepnev, Ph.D., describes a novel method of quantitative analysis of gene expression allowing simultaneous interrogation of multiple genes in a single tube reaction.
A study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is nearly one percent among newly incarcerated inmates with a history of recent drug use. Findings suggest that systematic screening of intravenous (IV) drug users who are new to the prison system could identify more than 7,000 cases of HCV across the U.S. annually—even among asymptomatic inmates.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicholas Calci, 790 Remington Blvd, Bolingbrook, IL 60440-4909 Ph: () - | Nicholas Calci, 2032 New Castle Ave, New Castle, DE 19720-7703 Ph: (302) 654-1700 |
News Archive
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, today announced the completion of a research study, conducted with an independent market research firm, that identified a significant unmet medical need for improved treatments for patients with chronic pain and dysphagia/odynophagia. In clinical practice, dysphagia is most often defined as difficulty in swallowing and odynophagia is defined as pain upon swallowing.
Increased relative risks for coronary heart disease (CHD) have long been associated with smoking, and traditionally they have been dependent on the number of cigarettes smoked a day, smoking intensities, and total exposure over time.
A Cochrane review of evidence to date has cast uncertainty over the magnitude of benefit children with attention deficit/hyperactivity gain by taking methylphenidate.
PrimeraDx, Inc., a privately held molecular diagnostics company, announced today that it has received its fourth patent. The patent, entitled "Methods and systems for dynamic gene expression profiling", with inventor Vladimir Slepnev, Ph.D., describes a novel method of quantitative analysis of gene expression allowing simultaneous interrogation of multiple genes in a single tube reaction.
A study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is nearly one percent among newly incarcerated inmates with a history of recent drug use. Findings suggest that systematic screening of intravenous (IV) drug users who are new to the prison system could identify more than 7,000 cases of HCV across the U.S. annually—even among asymptomatic inmates.
› Verified 6 days ago
Michael N Mount, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1214 Beaver Brook Plz Ste A, New Castle, DE 19720 Phone: 302-544-4388 | |
Barbara Unay, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 S Dupont Hwy Apt 117, New Castle, DE 19720 Phone: 623-383-0986 | |
Derek Alan Freshman, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2032 New Castle Ave, New Castle, DE 19720 Phone: 302-654-1700 | |
Ms. Kimberly Duch, PTH Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 318 E Basin Rd, New Castle, DE 19720 Phone: 302-323-2700 | |
Derek William Wiley, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2032 New Castle Ave, New Castle, DE 19720 Phone: 302-654-1700 Fax: 602-654-9474 | |
Laurie Ann Magerfleisch, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2032 New Castle Ave, New Castle, DE 19720 Phone: 302-654-1700 Fax: 302-654-9474 | |
Rebekah Coleman, Physical Therapist Medicare: Medicare Enrolled Practice Location: 100 Morrison Rd, New Castle, DE 19720 Phone: 302-690-5666 |